Table 1.
Demographic and Clinical Characteristics of the Intent-To-Treat Sample
| Characteristic | TOTAL (n=128) |
ACT (n=57) |
CBT (n=71) |
t value or χ2 |
p |
|---|---|---|---|---|---|
| Gender | |||||
| Female | 52.3% (67/128) |
50.0% (28/56) |
54.9% (39/71) |
.43 | .51 |
| Reported race/ethnicity | .82 | .36a | |||
| White | 67.2% (84/125) |
71.4% (40/56) |
63.8% (44/69) |
||
| Hispanic/Latino/a | 12.0% (15/125) |
10.7% (6/56) |
13.0% (9/69) |
||
| African-American/Black | 8.8% (11/125) |
7.1% (4/56) |
10.1% (7/69) |
||
| Asian-American/Pacific Islander | 8.0% (10/125) |
8.9% (5/56) |
7.2% (5/69) |
||
| American Indian/Alaskan Native | .08% (1/125) |
1.8% (1/56) |
0.0% (0/69) |
||
| Age, in years | 37.93 (11.70) Range: 19–60 |
38.16 (12.41) |
37.75 (11.19) |
−.20 | .85 |
| Education, in years | 15.41 (2.07) Range: 9–21 |
15.59 (2.01) |
15.27 (2.12) |
−.86 | .39 |
| Marital Status | .19 | .91a | |||
| Married/Cohabiting | 32.3% (41/127)b |
32.1% (18/56) |
32.4% (23/71) |
||
| Single | 58.3% (74/127) |
57.1% (32/56) |
59.2% (42/71) |
||
| Other | 10.2% (13/127) |
10.7% (6/56) |
8.5% (6/71) |
||
| Children (1+) | 28.0% (35/125) |
30.4% (17/56) |
26.1% (18/69) |
.28 | .60 |
| Currently on psychotropic medication | 48.0% (61/127) |
44.6% (25/56) |
50.7% (36/71) |
.46 | .50 |
|
| |||||
| Primary diagnosis | 4.67 | .32 | |||
| Panic disorder (with or without agoraphobia) | 41.7% (53/127) |
32.1% (18/56) |
49.3% (35/71) |
3.79 | .052 |
| Social anxiety disorder | 19.7% (25/127) |
23.2% (13/56) |
16.9% (12/71) |
.79 | .37 |
| Generalized anxiety disorder | 20.5% (26/127) |
25.0% (14/56) |
16.9% (12/71) |
1.26 | .26 |
| Obsessive-compulsive disorder | 13.4% (17/127) |
16.1% (9/56) |
11.3% (8/71) |
.62 | .43 |
| Specific Phobia | 4.7% (6/127) |
3.6% (2/56) |
5.6% (4/71) |
.69d | |
| Comorbid anxiety disorder (1+)c | 33.1% (42/127) |
39.3% (22/56) |
28.2% (20/71) |
1.75 | .19 |
| Comorbid depressive disorderc | 23.6% (30/127) |
23.2% (13/56) |
23.9% (17/71) |
.01 | .92 |
| Principal disorder clinical severity rating (mean) | 5.62 (.92) | 5.70 (.89) | 5.55 (.94) | .94 | .35 |
a
For race/ethnicity and marital status, analyses assessed group differences in minority versus white and married versus non-married status.
b
Demographic data was missing for 1 P.
c
Comorbidity was defined as a clinical severity rating of 4 or above on the ADIS
d
Fisher’s exact test p value was reported due to small n.